Il y a eu 50 transactions d'initiés récentes enregistrées pour Taysha Gene Therapies, Inc. (TSHA), dont 28 achats et 20 ventes. Le total des achats d'initiés s'élève à $34.8M et le total des ventes d'initiés à $3.01M.
Les initiés notables ayant une activité récente comprennent Alam Kamran, Nolan Sean P., Nagendran Sukumar. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — TSHA
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-02-04 |
Alam Kamran |
Chief Financial Officer |
Vente Informative |
1,655 |
$4.52 |
$7.48K |
1,442,131 |
| 2026-01-26 |
Nolan Sean P. |
Chief Executive Officer |
Vente Informative |
41,312 |
$4.61 |
$190.45K |
2,908,257 |
| 2026-01-26 |
Nagendran Sukumar |
President and Head of R&d |
Vente Informative |
26,918 |
$4.61 |
$124.09K |
1,317,389 |
| 2026-01-26 |
Alam Kamran |
Chief Financial Officer |
Vente Informative |
23,849 |
$4.61 |
$109.94K |
1,443,786 |
| 2026-01-23 |
Nolan Sean P. |
Chief Executive Officer |
Vente Informative |
136,789 |
$4.75 |
$649.75K |
2,949,569 |
| 2026-01-23 |
Nagendran Sukumar |
President and Head of R&d |
Vente Informative |
89,132 |
$4.75 |
$423.38K |
1,344,307 |
| 2026-01-23 |
Alam Kamran |
Chief Financial Officer |
Vente Informative |
78,968 |
$4.75 |
$375.1K |
1,467,635 |
| 2026-01-12 |
Nolan Sean P. |
Chief Executive Officer |
Attribution de RSU |
648,000 |
$4.86 |
$3.15M |
648,000 |
| 2026-01-12 |
Nagendran Sukumar |
President and Head of R&d |
Exercice d'Options (Vente) |
111,324 |
$0.70 |
$77.8K |
111,359 |
| 2026-01-12 |
Alam Kamran |
Chief Financial Officer |
Attribution de RSU |
231,000 |
$4.86 |
$1.12M |
231,000 |
| 2025-12-01 |
Nagendran Sukumar |
President and Head of R&d |
Exercice d'Options (Vente) |
260,047 |
$1.71 |
$444.68K |
563,617 |
| 2025-11-28 |
Nagendran Sukumar |
President and Head of R&d |
Exercice d'Options (Vente) |
70,172 |
$0.70 |
$49.04K |
222,683 |
| 2025-09-10 |
Nagendran Sukumar |
President and Head of R&d |
Exercice d'Options (Vente) |
41,150 |
$0.70 |
$28.76K |
292,855 |
| 2025-08-21 |
Nagendran Sukumar |
President and Head of R&d |
Vente Informative |
57,054 |
$2.85 |
$162.6K |
1,165,289 |
| 2025-08-21 |
Alam Kamran |
Chief Financial Officer |
Vente Informative |
54,491 |
$2.85 |
$155.3K |
1,187,603 |
| 2025-06-02 |
Donenberg Phillip B. |
Director |
Attribution de RSU |
113,246 |
$2.79 |
$315.39K |
113,246 |
| 2025-06-02 |
Stalfort John A Iii |
Director |
Attribution de RSU |
113,246 |
$2.79 |
$315.39K |
113,246 |
| 2025-06-02 |
Sepp-lorenzino Laura |
Director |
Attribution de RSU |
56,623 |
- |
- |
105,843 |
| 2025-06-02 |
Long Alison S |
Director |
Attribution de RSU |
56,623 |
- |
- |
105,843 |
| 2025-05-30 |
Manning Paul B |
10 Percent Owner |
Achat Informatif |
750,000 |
$2.75 |
$2.06M |
2,841,704 |
| 2025-03-11 |
Alam Kamran |
Chief Financial Officer |
Retenue Fiscale RSU |
29,843 |
$1.69 |
$50.43K |
1,242,094 |
| 2025-01-02 |
Nolan Sean P. |
Chief Executive Officer |
Attribution de RSU |
892,500 |
$1.85 |
$1.65M |
892,500 |
| 2025-01-02 |
Nagendran Sukumar |
President and Head of R&d |
Attribution de RSU |
324,500 |
$1.85 |
$600.33K |
324,500 |
| 2025-01-02 |
Alam Kamran |
Chief Financial Officer |
Attribution de RSU |
431,000 |
$1.85 |
$797.35K |
431,000 |
| 2024-06-27 |
Manning Paul B |
10 Percent Owner |
Achat Informatif |
1,333,333 |
$2.25 |
$3M |
1,333,333 |
| 2024-05-29 |
Donenberg Phillip B. |
Director |
Attribution de RSU |
98,440 |
$3.17 |
$312.05K |
98,440 |
| 2024-05-29 |
Stalfort John A Iii |
Director |
Attribution de RSU |
98,440 |
$3.17 |
$312.05K |
98,440 |
| 2024-05-29 |
Sepp-lorenzino Laura |
Director |
Attribution de RSU |
49,220 |
- |
- |
49,220 |
| 2024-05-29 |
Long Alison S |
Director |
Attribution de RSU |
49,220 |
- |
- |
49,220 |
| 2024-02-02 |
Alam Kamran |
Chief Financial Officer |
Retenue Fiscale RSU |
1,288 |
$1.51 |
$1.94K |
840,937 |
| 2024-01-02 |
Nolan Sean P. |
Chief Executive Officer |
Attribution de RSU |
1,184,688 |
$1.71 |
$2.03M |
1,184,688 |
| 2024-01-02 |
Nagendran Sukumar |
President and Head of R&d |
Attribution de RSU |
863,617 |
$1.71 |
$1.48M |
863,617 |
| 2024-01-02 |
Alam Kamran |
Chief Financial Officer |
Attribution de RSU |
590,413 |
$1.71 |
$1.01M |
590,413 |
| 2023-12-14 |
Nolan Sean P. |
Chief Executive Officer |
Attribution de RSU |
466,550 |
$0.70 |
$326.07K |
466,550 |
| 2023-12-14 |
Nagendran Sukumar |
President and Head of R&d |
Attribution de RSU |
334,005 |
$0.70 |
$233.44K |
334,005 |
| 2023-12-14 |
Alam Kamran |
Chief Financial Officer |
Attribution de RSU |
187,582 |
$0.70 |
$131.1K |
187,582 |
| 2023-11-17 |
Manning Paul B |
10 Percent Owner |
Achat Informatif |
100,000 |
$1.63 |
$163K |
16,566,667 |
| 2023-11-01 |
Long Alison S |
Director |
Inconnu |
- |
- |
- |
- |
| 2023-11-01 |
Long Alison S |
Director |
Attribution de RSU |
43,800 |
$2.39 |
$104.46K |
43,800 |
| 2023-08-24 |
Alam Kamran |
Chief Financial Officer |
Vente Informative |
33,000 |
$2.33 |
$76.89K |
258,042 |
| 2023-08-16 |
Donenberg Phillip B. |
Director |
Achat Informatif |
111,111 |
$0.90 |
$100K |
114,111 |
| 2023-08-16 |
Manning Paul B |
10 Percent Owner |
Achat Informatif |
16,466,667 |
$0.90 |
$14.82M |
16,466,667 |
| 2023-08-16 |
Nolan Sean P. |
Chief Executive Officer |
Achat Informatif |
444,444 |
$0.90 |
$400K |
1,535,545 |
| 2023-08-16 |
Stalfort John A Iii |
Director |
Achat Informatif |
388,889 |
$0.90 |
$350K |
884,290 |
| 2023-07-13 |
Session R.a. Ii |
10 Percent Owner |
Vente Informative |
5,344 |
$0.70 |
$3.74K |
8,871,747 |
| 2023-07-12 |
Session R.a. Ii |
10 Percent Owner |
Vente Informative |
80,528 |
$0.71 |
$57.03K |
8,877,091 |
| 2023-06-23 |
Session R.a. Ii |
10 Percent Owner |
Vente Informative |
18,100 |
$0.70 |
$12.74K |
8,957,619 |
| 2023-06-22 |
Donenberg Phillip B. |
Director |
Attribution de RSU |
36,200 |
$0.72 |
$26.06K |
36,200 |
| 2023-06-22 |
Session R.a. Ii |
10 Percent Owner |
Vente Informative |
10,508 |
$0.70 |
$7.38K |
8,975,719 |
| 2023-06-22 |
Stalfort John A Iii |
Director |
Inconnu |
- |
- |
- |
495,401 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi